HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Marksans Pharma’s arm gets Marketing Authorisation for Levetiracetam Relonchem Oral Solution
May-28-2024

Marksans Pharma’s wholly owned subsidiary -- Relonchem has received Marketing Authorization for the product Levetiracetam Relonchem 100 mg/mL Oral Solution from UK Medicines and Healthcare products Regulatory Agency (MHRA). The product will be manufactured at the Group’s UK manufacturing facility. 

Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.


  RELATED NEWS >>